The pathogenic role of APOL1 is emerging in several kidney diseases targeting podocytes and strong association between APOL1 high-risk Vs and progressive non-diabetic kidney disease [15, 26, 54], FSGS and HIVAN [11–17] have been reported. The gene discussed is APOL1; the disease is focal segmental glomerulosclerosis.